These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30218501)

  • 21. The expanding spectrum of clinically-distinctive, immunotherapy-responsive autoimmune encephalopathies.
    Irani SR; Vincent A
    Arq Neuropsiquiatr; 2012 Apr; 70(4):300-4. PubMed ID: 22510741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients.
    Iorio R; Damato V; Evoli A; Gessi M; Gaudino S; Di Lazzaro V; Spagni G; Sluijs JA; Hol EM
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):138-146. PubMed ID: 28951498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Movement disorders in autoimmune encephalitis and paraneoplastic neurological syndromes.
    Honnorat J; Joubert B
    Rev Neurol (Paris); 2018 Nov; 174(9):597-607. PubMed ID: 30201423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenic role of autoantibodies against inhibitory synapses.
    Prüss H; Kirmse K
    Brain Res; 2018 Dec; 1701():146-152. PubMed ID: 30205110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmune dementia and encephalopathy.
    Flanagan EP; Drubach DA; Boeve BF
    Handb Clin Neurol; 2016; 133():247-67. PubMed ID: 27112681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimmune and paraneoplastic movement disorders: An update.
    Baizabal-Carvallo JF; Jankovic J
    J Neurol Sci; 2018 Feb; 385():175-184. PubMed ID: 29406902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal central nervous system syndromes probably mediated by autoantibodies.
    Chefdeville A; Honnorat J; Hampe CS; Desestret V
    Eur J Neurosci; 2016 Jun; 43(12):1535-52. PubMed ID: 26918657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutamate Receptor Antibodies in Autoimmune Central Nervous System Disease: Basic Mechanisms, Clinical Features, and Antibody Detection.
    Scotton WJ; Karim A; Jacob S
    Methods Mol Biol; 2019; 1941():225-255. PubMed ID: 30707437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies associated with diseases of the CNS: new developments and future challenges.
    Vincent A; Bien CG; Irani SR; Waters P
    Lancet Neurol; 2011 Aug; 10(8):759-72. PubMed ID: 21777830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibody-mediated central nervous system channelopathies.
    Binks SNM; Irani SR
    Handb Clin Neurol; 2024; 203():235-269. PubMed ID: 39174251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel approaches and cutting edge immunotherapies in multiple sclerosis.
    Bauman TM; Kasper LH
    Front Biosci; 2004 Sep; 9():2302-22. PubMed ID: 15353289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human autoantibodies to amphiphysin induce defective presynaptic vesicle dynamics and composition.
    Werner C; Pauli M; Doose S; Weishaupt A; Haselmann H; Grünewald B; Sauer M; Heckmann M; Toyka KV; Asan E; Sommer C; Geis C
    Brain; 2016 Feb; 139(Pt 2):365-79. PubMed ID: 26582558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmune neurologic disorders in children.
    Lim M; Gorman M
    Handb Clin Neurol; 2016; 133():485-510. PubMed ID: 27112693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.
    Bien CG; Vincent A; Barnett MH; Becker AJ; Blümcke I; Graus F; Jellinger KA; Reuss DE; Ribalta T; Schlegel J; Sutton I; Lassmann H; Bauer J
    Brain; 2012 May; 135(Pt 5):1622-38. PubMed ID: 22539258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Movement disorders in systemic autoimmune diseases: Clinical spectrum, ancillary investigations, pathophysiological considerations.
    Menozzi E; Mulroy E; Akbarian-Tefaghi L; Bhatia KP; Balint B
    Parkinsonism Relat Disord; 2021 Jul; 88():116-128. PubMed ID: 34092506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GAD65 neurological autoimmunity.
    McKeon A; Tracy JA
    Muscle Nerve; 2017 Jul; 56(1):15-27. PubMed ID: 28063151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eye movement disorders and neurological symptoms in late-onset inborn errors of metabolism.
    Koens LH; Tijssen MAJ; Lange F; Wolffenbuttel BHR; Rufa A; Zee DS; de Koning TJ
    Mov Disord; 2018 Dec; 33(12):1844-1856. PubMed ID: 30485556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathophysiology and Prognostic Factors of Autoimmune Encephalitis].
    Prüß H
    Fortschr Neurol Psychiatr; 2016 May; 84(5):264-70. PubMed ID: 27299785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice.
    Outeiro TF; Kalia LV; Bezard E; Ferrario J; Lin CH; Salama M; Standaert DG; Taiwo L; Takahashi R; Vila M; Mollenhauer B; Svenningsson P;
    Mov Disord; 2024 Jun; 39(6):929-933. PubMed ID: 38576081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune-mediated disorders.
    Höftberger R; Lassmann H
    Handb Clin Neurol; 2017; 145():285-299. PubMed ID: 28987176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.